Adam Jeffery Views & Analysis The 2016 'Inspiring Hope' Ideathon - Day Two Coverage and re... Views & Analysis The 2016 'Inspiring Hope' Ideathon - Day One Coverage Partner Content Partner Content VIDEO: Streamlining the process of patient enrollment Ever more-specific cancer medicines carry the advantage of more personalised treatments for those with the disease. Partner Content Partner Content Overcoming the five challenges to effective immuno-oncology ... Recent advances have seen immuno-therapy become a shining light within oncology research, transforming both the way cancer treatments are viewed and the potential standards of care and outcomes. Load more results
Partner Content Partner Content VIDEO: Streamlining the process of patient enrollment Ever more-specific cancer medicines carry the advantage of more personalised treatments for those with the disease.
Partner Content Partner Content Overcoming the five challenges to effective immuno-oncology ... Recent advances have seen immuno-therapy become a shining light within oncology research, transforming both the way cancer treatments are viewed and the potential standards of care and outcomes.
Oncology ASCO 2026: First to first line in HER-2 NSCLC, with Itziar C... At ASCO 2026, BI Global Head of Oncology Itziar Canamasas spoke with pharmaphorum about the company's ASCO data and broader oncology strategy.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
